Neostigmine Methylsulfate Injection Solution recall: Labeling Error
Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile…
Why was Neostigmine Methylsulfate Injection Solution recalled?
Labeling: Label Error on Declared Strength: syringes of Neostigmine Methylsulfate 1 mg per mL, 5 mg per 5 mL may be incorrectly labeled as Neostigmine Methylsulfate 1 mg per mL, 3 mg per 3 mL.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot #: C274-000004690, BUD: 09/21/18.
- Product
- Neostigmine Methylsulfate Injection Solution, 5 mg per 5 mL, 1 mg per mL, 5 mL prefilled syringe, 5 syringes per package, Rx only, Fagron Sterile…
- Recalling firm
- Fagron Compounding Services LLC dba Fagron Sterile Services
- Quantity
- 840 prefilled syringes
- Distribution
- Nationwide in the USA
- Recall date
- July 11, 2018
- Classification
- Class I
- Status
- Terminated
- Agency
- FDA (drug)